Oral Answers to Questions

Kirsten Oswald Excerpts

Tuesday 1st March 2022 Commons Chamber

[Sajid Javid]

I once again express my condolences to my right hon. Friend for his loss. He is absolutely right to raise this issue and the need for more research. That is one of the reasons why, back in 2018, we announced £40 million of extra research funding over the next five years. I can tell him that some £9 million of that has already been committed to 10 projects. In addition, the Tessa Jowell Brain Matrix is an exciting new trials platform that will give people with brain cancer access to trials of treatments that are best suited for their individual tumours.

[Kirsten Oswald (East Renfrewshire) (SNP)]

T9. According to the Royal College of Obstetricians and Gynaecologists, less than 3% of medical research funding in the UK is focused on women-specific diseases such as endometriosis and polycystic ovary syndrome. They are serious conditions, but too little is known about them and we do not hear enough about them, especially polycystic ovary syndrome. The failure to increase research funding is holding back women’s outcomes and experiences. What are the UK Government doing to increase the priority given to research funding for both those conditions?

[Maria Caulfield]

The hon. Lady raises an important point. She is right that women are under-represented in clinical research and are waiting far too long for diagnoses of conditions such as endometriosis. The women’s health strategy will be published very shortly and I think that she will be pleased with some of its recommendations to drive improvements forward.